Showing results (421-430 of 501) with videos related to
Sort By:
Pageof 51
AIDS Research and Human Retroviruses|November 23, 2022
Pharmacokinetics, the Immunological Impact, and the Effect on HIV <i>Ex-Vivo</i> Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure ProphylaxisLorna Leal, Alberto C Guardo, Luis M Bedoya, et al.Journal of the International AIDS Society|October 5, 2014
Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammationBerta Torres, Alberto C Guardo, Lorna Leal, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 29, 2011
Reinforced Portland cement porous scaffolds for load-bearing bone tissue engineering applicationsNatalia Higuita-Castro, Daniel Gallego-Perez, Alejandro Pelaez-Vargas, et al.Journal of Internal Medicine|March 28, 2022
Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs)Cristina Gálvez, Víctor Urrea, Maria Del Carmen Garcia-Guerrero, et al.Antiviral Therapy|May 28, 2005
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patientsMontse Laguno, Ana Milinkovic, Elisa de Lazzari, et al.European Journal of Haematology|March 31, 2011
Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopeniaCarlos Cervera, Francesc Fernández-Avilés, Oscar de la Calle-Martin, et al.The Journal of Antimicrobial Chemotherapy|March 20, 2016
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infectionLorna Leal, Agathe León, Berta Torres, et al.The Journal of Antimicrobial Chemotherapy|March 20, 2016
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infectionLorna Leal, Agathe León, Berta Torres, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot studyFelipe García, Montserrat Plana, Mireia Arnedo, et al.Journal of Medical Case Reports|February 26, 2025
Late-onset Sheehan's syndrome: a major diagnostic challenge-a case reportLuis Miguel Osorio-Toro, Yessica Alejandra Ordoñez-Guzman, Jhon Fernando Montenegro-Palacios, et al.Pageof 51